Weekly Intelligence · 1 articles
Vet Industry Intel: Mar 15 – Mar 21, 2026
High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.
Products & Technology (1)
Products & Technology
Mar 18, 2026 [9/10] fda_cvm
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs - Business Wire
The FDA approved Merck Animal Health's Bravecto Quantum, an extended-release injectable suspension providing 12 months of protection against certain tick species in dogs.
FDA · Merck Animal Health · Business Wire